SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-17-000440
Filing Date
2017-06-12
Accepted
2017-06-12 16:34:57
Documents
1
Period of Report
2017-06-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 8815
  Complete submission text file 0000904454-17-000440.txt   10293
Mailing Address
Business Address
TREU JESSE I (Reporting) CIK: 0001013425 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-36332 | Film No.: 17906923

Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Issuer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations